Pathwork Diagnostics Study: Gene Testing of Fluid Specimens Helps Identify Cancer Origin

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced that results demonstrating the capability of its Tissue of Origin Test to be performed on a variety of FFPE fluid specimens will be presented this week at the 100th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) in San Antonio, TX.

MORE ON THIS TOPIC